GENFIT Stock Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
02:02:15 2026-08-14 am EDT
|
5-day change | 1st Jan Change | ||
| 13.32 EUR | +2.46% |
|
-2.20% | +153.96% |
| Jul. 03 | Genfit soars on news of U.S. reimbursement for a product |  |
| Jul. 03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 651M 754M 612M 557M 1.05B 72.11B 1.06B 7.17B 2.8B 36.11B 2.83B 2.77B 120B | P/E 2026 * |
33.6x | P/E 2027 * | 86.5x |
|---|---|---|---|---|---|
| Enterprise Value | 600M 695M 564M 513M 964M 66.45B 980M 6.61B 2.58B 33.28B 2.61B 2.55B 111B | EV / Sales 2026 * |
5.99x | EV / Sales 2027 * | 4.72x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.46% | ||
| 1 week | -2.20% | ||
| Current month | -4.99% | ||
| 1 month | +2.30% | ||
| 3 months | +52.40% | ||
| 6 months | +88.80% | ||
| Current year | +153.96% |
| 1 week | 12.72 |  | 14.16 |
| 1 month | 12.72 | | 14.86 |
| Current year | 5.08 | | 14.86 |
| 1 year | 3.01 | | 14.86 |
| 3 years | 2.8 | | 14.86 |
| 5 years | 2.74 | | 14.86 |
| 10 years | 2.74 | | 33.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.46% | -2.20% | - | - | 754M | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| Average | -0.35% | +0.49% | +78.02% | +110.46% | 29.24B | |
| Weighted average by Cap. | -0.90% | +0.59% | +95.83% | +132.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 116M 94.15M 85.63M 161M 11.09B 164M 1.1B 431M 5.56B 436M 426M 18.46B | 124M 144M 117M 106M 199M 13.73B 203M 1.37B 534M 6.88B 539M 528M 22.85B |
| Net income | 22.88M 26.49M 21.5M 19.55M 36.76M 2.53B 37.36M 252M 98.49M 1.27B 99.45M 97.29M 4.22B | 6.8M 7.87M 6.39M 5.81M 10.93M 753M 11.11M 74.87M 29.27M 377M 29.56M 28.92M 1.25B |
| Net Debt | -51.12M -59.18M -48.03M -43.68M -82.13M -5.66B -83.49M -563M -220M -2.83B -222M -217M -9.42B | -66.17M -76.62M -62.18M -56.55M -106M -7.33B -108M -729M -285M -3.67B -288M -281M -12.19B |
| Date | Price | Change |
|---|---|---|
| 26-08-14 | €13.32 | +2.46% |
| 26-08-13 | €13.00 | +2.20% |
| 26-08-12 | €12.72 | -2.60% |
| 26-08-11 | €13.06 | -7.77% |
| 26-08-10 | €14.16 | +3.96% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
